SG Americas Securities LLC Purchases 80,534 Shares of Encompass Health Corporation $EHC

SG Americas Securities LLC boosted its position in shares of Encompass Health Corporation (NYSE:EHC) by 1,070.9% in the fourth quarter, Holdings Channel reports. The firm owned 88,054 shares of the company’s stock after purchasing an additional 80,534 shares during the period. SG Americas Securities LLC’s holdings in Encompass Health were worth $9,346,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Norges Bank bought a new position in shares of Encompass Health during the second quarter worth $139,536,000. Millennium Management LLC increased its position in shares of Encompass Health by 140.0% in the 3rd quarter. Millennium Management LLC now owns 1,223,665 shares of the company’s stock valued at $155,430,000 after buying an additional 713,738 shares in the last quarter. 8 Knots Management LLC acquired a new stake in Encompass Health during the 2nd quarter worth $78,644,000. Alliancebernstein L.P. lifted its holdings in Encompass Health by 23.4% during the third quarter. Alliancebernstein L.P. now owns 2,515,878 shares of the company’s stock worth $319,567,000 after acquiring an additional 476,564 shares in the last quarter. Finally, Thrivent Financial for Lutherans grew its stake in Encompass Health by 57.8% in the third quarter. Thrivent Financial for Lutherans now owns 1,194,859 shares of the company’s stock valued at $151,544,000 after acquiring an additional 437,464 shares during the period. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday, January 18th. Barclays boosted their price objective on Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a research report on Friday, February 6th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $143.29.

Encompass Health Stock Performance

EHC opened at $97.73 on Monday. The business’s 50-day simple moving average is $102.57 and its 200 day simple moving average is $111.11. Encompass Health Corporation has a 52-week low of $92.77 and a 52-week high of $127.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 1.08. The firm has a market capitalization of $9.72 billion, a PE ratio of 17.64, a PEG ratio of 1.87 and a beta of 0.70.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, February 5th. The company reported $1.46 earnings per share for the quarter, beating analysts’ consensus estimates of $1.29 by $0.17. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.The firm had revenue of $3.09 billion during the quarter, compared to the consensus estimate of $1.54 billion. During the same period last year, the company earned $1.17 earnings per share. The business’s revenue was up 9.9% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. As a group, sell-side analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st will be issued a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Wednesday, April 1st. Encompass Health’s payout ratio is presently 13.72%.

Insider Buying and Selling at Encompass Health

In other news, Treasurer Edmund Fay sold 11,937 shares of Encompass Health stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $107.00, for a total value of $1,277,259.00. Following the completion of the transaction, the treasurer owned 89,325 shares of the company’s stock, valued at $9,557,775. This trade represents a 11.79% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Mark J. Tarr sold 150,000 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $111.64, for a total transaction of $16,746,000.00. Following the completion of the sale, the chief executive officer directly owned 377,070 shares in the company, valued at approximately $42,096,094.80. The trade was a 28.46% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 2.10% of the company’s stock.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.